Last reviewed · How we verify

NCT03303781

BeSingCardioRehab: CR in Belgium Versus Singapore

Completed Last updated 9 February 2021
What this trial tests

trial testing Cardiac Rehabilitation in Ischemic Heart Disease in 2,792 participants. Completed in 1 January 2021.

Timeline
1 April 2018
Primary endpoint
1 September 2020
1 January 2021

Quick facts

Lead sponsorHasselt University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,792
Start date1 April 2018
Primary completion1 September 2020
Estimated completion1 January 2021
Sites2 locations across Belgium, Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Cardiac rehabilitation is indicated for ischemic heart disease patients; the program content of which is well described in both European and American guidelines. In contrast, literature on cardiac rehabilitation program content and efficacy in the Asian population is sparse. Methods: BeSingCardioRehab will be an intercontinental, retrospective cohort study conducted in two cardiac rehabilitation referral centers in Belgium and Singapore. The first aim is to compare the impact of phase II center-based cardiac rehabilitation on Major Adverse Cardiac Events for ischemic heart disease patients between Europe (i.e. Belgian) and Asia (i.e. Singaporean) in the long-term. The second objective is to compare the efficacy of phase II cardiac rehabilitation on short-term morbidity (assessed with the validated SMART Risk Score) between index European and Asian ischemic heart disease patients. The level of compliance of the Belgian and Singaporean cardiac rehabilitation programs to European guidelines standards will also be evaluated. Hypotheses BeSingCardiorehab will be one of the first studies assessing cardiac rehabilitation in Asia. Based on the BeSingCardioRehab study results, phase II center-based cardiac rehabilitation programs, can/will be adapted in order to improve program content and outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cardiac Rehabilitation

Trials testing the same drug.

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03303781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing